Safinamide vs Co-beneldopa (Benserazide/levodopa)
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 20.3× as often as Safinamide in May 2026 — 77,476 items versus 3,824 in England.
3,824items
Safinamide · May 2026
NHSBSA Prescription Cost Analysis
77,476items
Co-beneldopa (Benserazide/levodopa) · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Safinamide versus Co-beneldopa (Benserazide/levodopa): national items dispensed by month
▬ Safinamide · ╌ Co-beneldopa (Benserazide/levodopa)
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Safinamide | Co-beneldopa (Benserazide/levodopa) |
|---|---|---|
| Items, May 2026 | 3,824 | 77,476 |
| Items, last 12 months | 45,537 | 948,791 |
| Net ingredient cost, May 2026 | £257,496 | £953,642 |
See the full profile for Safinamide or Co-beneldopa (Benserazide/levodopa).